StreetAlpha.app
Home › Stocks › WHWK

Whitehawk Therapeutics, Inc. (WHWK)

$3.08
▲ +2.33%
LAST CLOSE · NOV 17

Whitehawk Therapeutics develops antibody drug conjugates for cancer treatment, with its candidates in early clinical trials and based in New Jersey. It last closed at $3.08 on Nov 17, up 2.33% on the day.

AI Auto Pilots
Is WHWK in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$0
−100.0% vs a year ago
Net income
−$83.3M
EPS (diluted)
−$1.10
Free cash flow
−$73.6M
Valuation
Market cap
$181.7M
59.0M shares
P/E
–
No P/E while losing money
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$69.0M
At Sep 30
Shareholder equity
$163.2M
Shares outstanding
59.0M
At Nov 5
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $14.0M$14.0MFY2021FY2022: $15.2M$15.2MFY2022FY2023: $24.4M$24.4MFY2023FY2024: $26.0M$26.0MFY2024FY2025: $7.1M$7.1MFY2025

From WHWK's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 9). Last 12 months adds up the four latest quarters.

Last report
Nov 9
2026 · next date not on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
1 Buy
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy
1firm
1 Buy0 Hold0 Sell
Only 1 firm rated WHWK in the past 90 days, not enough for a consensus
Average 12-month target
$9.00
▲ 192.2% upside

Based on 1 analyst who set a price target on WHWK in the past 90 days. The average target is $9.00, with a high of $9.00 and a low of $9.00, compared with the last close of $3.08.

Low $9.00Avg $9.00High $9.00
Blue marker: last close $3.08
Highest target$9.00
Average target$9.00
Lowest target$9.00
Latest rating changes
StifelInitiated
Oct 1Buy$9
Leerink PartnersInitiated
Jul 13Buy$9
B. Riley SecuritiesInitiated
Jun 25Buy$10
CitizensInitiated
Apr 16Buy$8
DateFirmActionRatingPrice target
Oct 1StifelInitiatedBuy$9
Jul 13Leerink PartnersInitiatedBuy$9
Jun 25B. Riley SecuritiesInitiatedBuy$10
Apr 16CitizensInitiatedBuy$8
Loading…

Technical Analysis

WHWK · as of the Nov 17 close · updated after every close
Downtrend

The stock is 3% below its 20 day and 13% below its 50 day average. It is 25% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 44). The nearest support is the Pivot at $3.03, and the nearest resistance the Pivot R1 at $3.15.

Short trendBearish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityNormal, 6.6%/day
Key levels
$5.5052 week high+78.6%
$3.89100 day average+26.3%
$3.86200 day average+25.3%
$3.4850 day average+13.0%
$3.37Swing high (Oct 22)+9.4%
$3.1820 day average+3.2%
$3.15Pivot R1+2.3%
$3.08Last close
$3.03Pivot−1.6%
$2.96Pivot S1−3.9%
$2.91Swing low (Nov 5)−5.5%
$1.9752 week low−36.0%
Indicators
RSI (14)43.80Middle of its rangeNeutral
MACD-0.11Above its signal lineBullish
Stochastic23.3Middle of its rangeNeutral
ADX (14)22.0Weak trend
Williams %R-71.7Oversold below −80, overbought above −20Neutral
CCI (20)-105.9Oversold below −100, overbought above 100Oversold
Rate of change−0.7%Change over 10 sessionsBearish
ATR (14)$0.20Typical daily range, 6.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for WHWK

What happened before

See how WHWK did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow WHWK usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How WHWK has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2017.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in WHWK in the last 90 days.

Loading…

See today’s whale options flow across the market →

WHWK Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲59 buying vs 22 selling
  • ▲Held by funds +1.4 pts
  • ▲Funds holding +13
  • ●Superinvestors: 2 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding9178+16.7%
In funds' top 1034−25.0%
Held by funds74.6%73.3%+1.4 pts
New / increased21 / 3829 / 29+1.7%
Reduced / sold out13 / 911 / 12−4.3%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See WHWK institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether WHWK is in one of them and how their past WHWK trades turned out.

WHWK in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered WHWK in an article yet. Here's the latest on the wider market.

About Whitehawk Therapeutics

Whitehawk Therapeutics is a drug developer based in Morristown, New Jersey, focused on cancer treatments. It is developing antibody drug conjugates, a type of treatment designed to deliver a cell-killing drug directly to tumor cells. Its product candidates are in early clinical trials for solid tumors such as lung, ovarian and endometrial cancers. The company's intended customers are cancer patients and the medical providers who treat them.

Headquarters
Morristown, NJ